Hilleman Laboratories Pvt. Ltd.

Industry

  • Academic and Research Institutions
See more in Biomedtracker

Latest on Hilleman Laboratories Pvt. Ltd.

Scrip

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim GmbH is closely

Scrip

Former Hilleman CEO On Microbiome Project, Cholera, Halal Vaccine

 
• By Vibha Ravi

“The best vaccine in the world for young children is mother’s milk,” declares the former CEO of Indian vaccine firm Hilleman Laboratories Pvt. Ltd. Davinder Gill, calling the microbiome in it a “mag

Scrip

Asia Deal Watch: Dr Reddy’s Licenses Coya’s ALS Combo Drug

 
• By Joseph Haas and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Coya And Dr Reddy’s Ink Deal For C

Scrip

Asia Deal Watch: Maruho Licenses Rights In Japan To GI Innovation’s Allergy Candidate

 
• By Jung Won Shin, Vibha Ravi, Lisa Takagi, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Maruho Obtains Rights To GI-301 No